Regional distribution and kinetics of haloperidol binding in human brain

A PET study with [18F]haloperidol

D. J. Schlyer, N. D. Volkow, J. S. Fowler, A. P. Wolf, C. Y. Shiue, S. L. Dewey, B. Bendriem, J. Logan, R. Raulli, Robert Hitzemann, J. Brodie, A. A. Alavi, R. R. MacGregor

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

The regional distribution and the kinetics of haloperidol uptake in human brain were examined using [18F]haloperidol and PET in 9 controls and 5 schizophrenics while on haloperidol medication and after haloperidol washout. The regional distribution of [18F]N-methylspiroperidol, a tracer for D2 receptors, was measured in 1 normal subject for comparison. The uptake of [18F]haloperidol in the whole brain in normals was high (6.6% of the injected dose at 2 hr), and regional distribution was much more extensive than could be accounted for by the distribution of dopamine D2 receptors. In normals, the cerebellum, basal ganglia, and thalamus showed a greater concentration than the cortex, and there was minimal clearance of 18F from the brain during the 10-hr period of the study. Medicated schizophrenics showed a total brain uptake of 4.0% and had a significant clearance of [18F]haloperidol from brain and a higher concentration of [18F]haloperidol in plasma. After withdrawal from medication, [18F]haloperidol clearance from brain became slower than while on medication. These results are discussed in terms of the pharmacokinetics of haloperidol in the human brain and its binding to dopamine D2 receptors and to sigma receptors.

Original languageEnglish (US)
Pages (from-to)10-19
Number of pages10
JournalSynapse
Volume11
Issue number1
DOIs
StatePublished - 1992
Externally publishedYes

Fingerprint

Haloperidol
Brain
Dopamine D2 Receptors
sigma Receptors
Basal Ganglia
Thalamus
Cerebellum
Pharmacokinetics

ASJC Scopus subject areas

  • Neuroscience(all)
  • Physiology
  • Pharmacology

Cite this

Schlyer, D. J., Volkow, N. D., Fowler, J. S., Wolf, A. P., Shiue, C. Y., Dewey, S. L., ... MacGregor, R. R. (1992). Regional distribution and kinetics of haloperidol binding in human brain: A PET study with [18F]haloperidol. Synapse, 11(1), 10-19. https://doi.org/10.1002/syn.890110103

Regional distribution and kinetics of haloperidol binding in human brain : A PET study with [18F]haloperidol. / Schlyer, D. J.; Volkow, N. D.; Fowler, J. S.; Wolf, A. P.; Shiue, C. Y.; Dewey, S. L.; Bendriem, B.; Logan, J.; Raulli, R.; Hitzemann, Robert; Brodie, J.; Alavi, A. A.; MacGregor, R. R.

In: Synapse, Vol. 11, No. 1, 1992, p. 10-19.

Research output: Contribution to journalArticle

Schlyer, DJ, Volkow, ND, Fowler, JS, Wolf, AP, Shiue, CY, Dewey, SL, Bendriem, B, Logan, J, Raulli, R, Hitzemann, R, Brodie, J, Alavi, AA & MacGregor, RR 1992, 'Regional distribution and kinetics of haloperidol binding in human brain: A PET study with [18F]haloperidol', Synapse, vol. 11, no. 1, pp. 10-19. https://doi.org/10.1002/syn.890110103
Schlyer, D. J. ; Volkow, N. D. ; Fowler, J. S. ; Wolf, A. P. ; Shiue, C. Y. ; Dewey, S. L. ; Bendriem, B. ; Logan, J. ; Raulli, R. ; Hitzemann, Robert ; Brodie, J. ; Alavi, A. A. ; MacGregor, R. R. / Regional distribution and kinetics of haloperidol binding in human brain : A PET study with [18F]haloperidol. In: Synapse. 1992 ; Vol. 11, No. 1. pp. 10-19.
@article{5996e7d76ca6447085f07c12538ed0cd,
title = "Regional distribution and kinetics of haloperidol binding in human brain: A PET study with [18F]haloperidol",
abstract = "The regional distribution and the kinetics of haloperidol uptake in human brain were examined using [18F]haloperidol and PET in 9 controls and 5 schizophrenics while on haloperidol medication and after haloperidol washout. The regional distribution of [18F]N-methylspiroperidol, a tracer for D2 receptors, was measured in 1 normal subject for comparison. The uptake of [18F]haloperidol in the whole brain in normals was high (6.6{\%} of the injected dose at 2 hr), and regional distribution was much more extensive than could be accounted for by the distribution of dopamine D2 receptors. In normals, the cerebellum, basal ganglia, and thalamus showed a greater concentration than the cortex, and there was minimal clearance of 18F from the brain during the 10-hr period of the study. Medicated schizophrenics showed a total brain uptake of 4.0{\%} and had a significant clearance of [18F]haloperidol from brain and a higher concentration of [18F]haloperidol in plasma. After withdrawal from medication, [18F]haloperidol clearance from brain became slower than while on medication. These results are discussed in terms of the pharmacokinetics of haloperidol in the human brain and its binding to dopamine D2 receptors and to sigma receptors.",
author = "Schlyer, {D. J.} and Volkow, {N. D.} and Fowler, {J. S.} and Wolf, {A. P.} and Shiue, {C. Y.} and Dewey, {S. L.} and B. Bendriem and J. Logan and R. Raulli and Robert Hitzemann and J. Brodie and Alavi, {A. A.} and MacGregor, {R. R.}",
year = "1992",
doi = "10.1002/syn.890110103",
language = "English (US)",
volume = "11",
pages = "10--19",
journal = "Synapse",
issn = "0887-4476",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Regional distribution and kinetics of haloperidol binding in human brain

T2 - A PET study with [18F]haloperidol

AU - Schlyer, D. J.

AU - Volkow, N. D.

AU - Fowler, J. S.

AU - Wolf, A. P.

AU - Shiue, C. Y.

AU - Dewey, S. L.

AU - Bendriem, B.

AU - Logan, J.

AU - Raulli, R.

AU - Hitzemann, Robert

AU - Brodie, J.

AU - Alavi, A. A.

AU - MacGregor, R. R.

PY - 1992

Y1 - 1992

N2 - The regional distribution and the kinetics of haloperidol uptake in human brain were examined using [18F]haloperidol and PET in 9 controls and 5 schizophrenics while on haloperidol medication and after haloperidol washout. The regional distribution of [18F]N-methylspiroperidol, a tracer for D2 receptors, was measured in 1 normal subject for comparison. The uptake of [18F]haloperidol in the whole brain in normals was high (6.6% of the injected dose at 2 hr), and regional distribution was much more extensive than could be accounted for by the distribution of dopamine D2 receptors. In normals, the cerebellum, basal ganglia, and thalamus showed a greater concentration than the cortex, and there was minimal clearance of 18F from the brain during the 10-hr period of the study. Medicated schizophrenics showed a total brain uptake of 4.0% and had a significant clearance of [18F]haloperidol from brain and a higher concentration of [18F]haloperidol in plasma. After withdrawal from medication, [18F]haloperidol clearance from brain became slower than while on medication. These results are discussed in terms of the pharmacokinetics of haloperidol in the human brain and its binding to dopamine D2 receptors and to sigma receptors.

AB - The regional distribution and the kinetics of haloperidol uptake in human brain were examined using [18F]haloperidol and PET in 9 controls and 5 schizophrenics while on haloperidol medication and after haloperidol washout. The regional distribution of [18F]N-methylspiroperidol, a tracer for D2 receptors, was measured in 1 normal subject for comparison. The uptake of [18F]haloperidol in the whole brain in normals was high (6.6% of the injected dose at 2 hr), and regional distribution was much more extensive than could be accounted for by the distribution of dopamine D2 receptors. In normals, the cerebellum, basal ganglia, and thalamus showed a greater concentration than the cortex, and there was minimal clearance of 18F from the brain during the 10-hr period of the study. Medicated schizophrenics showed a total brain uptake of 4.0% and had a significant clearance of [18F]haloperidol from brain and a higher concentration of [18F]haloperidol in plasma. After withdrawal from medication, [18F]haloperidol clearance from brain became slower than while on medication. These results are discussed in terms of the pharmacokinetics of haloperidol in the human brain and its binding to dopamine D2 receptors and to sigma receptors.

UR - http://www.scopus.com/inward/record.url?scp=0026535297&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026535297&partnerID=8YFLogxK

U2 - 10.1002/syn.890110103

DO - 10.1002/syn.890110103

M3 - Article

VL - 11

SP - 10

EP - 19

JO - Synapse

JF - Synapse

SN - 0887-4476

IS - 1

ER -